These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20134265)

  • 21. [Effects of small interfering RNA specific to stably transfected HMGA1 gene on biological characters of ovarian carcinoma cells].
    Liu YL; Zheng JH
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):51-5. PubMed ID: 20367927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: relevance to prostate cancer and benign hyperplasia.
    Zeng Y; Kakehi Y; Nouh MA; Tsunemori H; Sugimoto M; Wu XX
    Prostate; 2009 Feb; 69(3):283-92. PubMed ID: 19025891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.
    Kioi M; Kawakami M; Shimamura T; Husain SR; Puri RK
    Cancer; 2006 Sep; 107(6):1407-18. PubMed ID: 16902988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
    Bellone S; Siegel ER; Cocco E; Cargnelutti M; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Int J Gynecol Cancer; 2009 Jul; 19(5):860-6. PubMed ID: 19574774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATX-LPA axis induces expression of OPN in hepatic cancer cell SMMC7721.
    Zhang R; Zhang Z; Pan X; Huang X; Huang Z; Zhang G
    Anat Rec (Hoboken); 2011 Mar; 294(3):406-11. PubMed ID: 21337710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.
    Makii C; Oda K; Ikeda Y; Sone K; Hasegawa K; Uehara Y; Nishijima A; Asada K; Koso T; Fukuda T; Inaba K; Oki S; Machino H; Kojima M; Kashiyama T; Mori-Uchino M; Arimoto T; Wada-Hiraike O; Kawana K; Yano T; Fujiwara K; Aburatani H; Osuga Y; Fujii T
    Oncotarget; 2016 Nov; 7(46):75328-75338. PubMed ID: 27659536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival.
    Amano Y; Mandai M; Yamaguchi K; Matsumura N; Kharma B; Baba T; Abiko K; Hamanishi J; Yoshioka Y; Konishi I
    Oncotarget; 2015 Sep; 6(28):26002-17. PubMed ID: 26318292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells.
    Basaki Y; Hosoi F; Oda Y; Fotovati A; Maruyama Y; Oie S; Ono M; Izumi H; Kohno K; Sakai K; Shimoyama T; Nishio K; Kuwano M
    Oncogene; 2007 Apr; 26(19):2736-46. PubMed ID: 17072343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutathione peroxidase 3 is a candidate mechanism of anticancer drug resistance of ovarian clear cell adenocarcinoma.
    Saga Y; Ohwada M; Suzuki M; Konno R; Kigawa J; Ueno S; Mano H
    Oncol Rep; 2008 Dec; 20(6):1299-303. PubMed ID: 19020706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G Protein-Coupled Receptor 30 Mediates the Anticancer Effects Induced by Eicosapentaenoic Acid in Ovarian Cancer Cells.
    Zhao Y; Zhao MF; Yang ML; Wu TY; Xu CJ; Wang JM; Li CJ; Li X
    Cancer Res Treat; 2020 Jul; 52(3):815-829. PubMed ID: 32138466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma.
    Lee S; Garner EI; Welch WR; Berkowitz RS; Mok SC
    Gynecol Oncol; 2007 Aug; 106(2):311-7. PubMed ID: 17532031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NFATc1 regulates cell proliferation, migration, and invasion of ovarian cancer SKOV3 cells in vitro and in vivo.
    Li L; Duan Z; Yu J; Dang HX
    Oncol Rep; 2016 Aug; 36(2):918-28. PubMed ID: 27350254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of salusin-β is associated with poor prognosis in ovarian cancer.
    Zhang Q; Chen WM; Zhang XX; Zhang HX; Wang HC; Zheng FY; Zhu FF
    Oncol Rep; 2017 Mar; 37(3):1826-1832. PubMed ID: 28184918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma.
    Jagadish N; Fatima R; Sharma A; Devi S; Suri V; Kumar V; Suri A
    Tumour Biol; 2018 May; 40(5):1010428318773652. PubMed ID: 29745297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of integrin alpha3 expression associated with acquisition of invasive potential by ovarian clear cell adenocarcinoma cells.
    Suzuki N; Higashiguchi A; Hasegawa Y; Matsumoto H; Oie S; Orikawa K; Ezawa S; Susumu N; Miyashita K; Aoki D
    Hum Cell; 2005 Sep; 18(3):147-55. PubMed ID: 17022147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical Efficacy for AKT Targeting in Clear Cell Carcinoma of the Ovary.
    Sasano T; Mabuchi S; Kuroda H; Kawano M; Matsumoto Y; Takahashi R; Hisamatsu T; Sawada K; Hashimoto K; Isobe A; Testa JR; Kimura T
    Mol Cancer Res; 2015 Apr; 13(4):795-806. PubMed ID: 25519148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticancer effects of chemokine receptor 4(CXCR4) gene silenced by CXCR4-siRNA in nude mice model of ovarian cancer.
    Liu W; Wang Y; Wang H; Wang A
    Cell Biochem Biophys; 2014 Dec; 70(3):1893-900. PubMed ID: 25149650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRPC channels and their splice variants are essential for promoting human ovarian cancer cell proliferation and tumorigenesis.
    Zeng B; Yuan C; Yang X; Atkin SL; Xu SZ
    Curr Cancer Drug Targets; 2013 Jan; 13(1):103-16. PubMed ID: 22920441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer.
    Wang-Johanning F; Liu J; Rycaj K; Huang M; Tsai K; Rosen DG; Chen DT; Lu DW; Barnhart KF; Johanning GL
    Int J Cancer; 2007 Jan; 120(1):81-90. PubMed ID: 17013901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin.
    Kim A; Enomoto T; Serada S; Ueda Y; Takahashi T; Ripley B; Miyatake T; Fujita M; Lee CM; Morimoto K; Fujimoto M; Kimura T; Naka T
    Int J Cancer; 2009 Nov; 125(10):2316-22. PubMed ID: 19598262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.